The Valley Desk

NCT02960204 · Interventional trial

Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension

Overall registry status Completed

Phase 2

Conditions Cirrhosis, Non-alcoholic Steatohepatitis, Portal Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov